Evidence map›Paper›PMID 36158684›Full record

ArticleFrontiers in oncology2022

Machine learning models predict lymph node metastasis in patients with stage T1-T2 esophageal squamous cell carcinoma.

Dong-Lin Li, Lin Zhang, Hao-Ji Yan, Yin-Bin Zheng, Xiao-Guang Guo, Sheng-Jie Tang, Hai-Yang Hu, Hang Yan, Chao Qin, Jun Zhang and 3 more

Abstract read
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Dong-Lin LiDepartment of Thoracic Surgery, Suining Central Hospital, Sunning, China.
Lin ZhangDepartment of Thoracic Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.
Hao-Ji YanDepartment of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, China.
Yin-Bin ZhengDepartment of Thoracic Surgery, Nanchong Central Hospital, Nanchong, China.
Xiao-Guang GuoDepartment of Pathology, Nanchong Central Hospital, Nanchong, China.
Sheng-Jie TangDepartment of Thoracic Surgery, Suining Central Hospital, Sunning, China.
Hai-Yang HuDepartment of Thoracic Surgery, Suining Central Hospital, Sunning, China.
Hang YanDepartment of Thoracic Surgery, Suining Central Hospital, Sunning, China.
Chao QinDepartment of Thoracic Surgery, Suining Central Hospital, Sunning, China.
Jun ZhangDepartment of Thoracic Surgery, Suining Central Hospital, Sunning, China.
Hai-Yang GuoDepartment of Thoracic Surgery, Suining Central Hospital, Sunning, China.
Hai-Ning ZhouDepartment of Thoracic Surgery, Suining Central Hospital, Sunning, China.
Dong TianDepartment of Thoracic Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: For patients with stage T1-T2 esophageal squamous cell carcinoma (ESCC), accurately predicting lymph node metastasis (LNM) remains challenging. We aimed to investigate the performance of machine learning (ML) models for predicting LNM in patients with stage T1-T2 ESCC. Methods: Patients with T1-T2 ESCC at three centers between January 2014 and December 2019 were included in this retrospective study and divided into training and external test sets. All patients underwent esophagectomy and were pathologically examined to determine the LNM status. Thirty-six ML models were developed using six modeling algorithms and six feature selection techniques. The optimal model was determined by the bootstrap method. An external test set was used to further assess the model's generalizability and effectiveness. To evaluate prediction performance, the area under the receiver operating characteristic curve (AUC) was applied. Results: Of the 1097 included patients, 294 (26.8%) had LNM. The ML models based on clinical features showed good predictive performance for LNM status, with a median bootstrapped AUC of 0.659 (range: 0.592, 0.715). The optimal model using the naive Bayes algorithm with feature selection by determination coefficient had the highest AUC of 0.715 (95% CI: 0.671, 0.763). In the external test set, the optimal ML model achieved an AUC of 0.752 (95% CI: 0.674, 0.829), which was superior to that of T stage (0.624, 95% CI: 0.547, 0.701). Conclusions: ML models provide good LNM prediction value for stage T1-T2 ESCC patients, and the naive Bayes algorithm with feature selection by determination coefficient performed best.

Indexed as

esophageal squamous cell carcinomalymph node metastasismachine learningpredictive modelstage T1-T2

Identifiers

PMID36158684
PMCPMC9496653

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.